Feipu Yang

526 total citations
27 papers, 156 citations indexed

About

Feipu Yang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Feipu Yang has authored 27 papers receiving a total of 156 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 8 papers in Organic Chemistry. Recurrent topics in Feipu Yang's work include Pharmacological Receptor Mechanisms and Effects (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Receptor Mechanisms and Signaling (8 papers). Feipu Yang is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (9 papers), Neuroscience and Neuropharmacology Research (8 papers) and Receptor Mechanisms and Signaling (8 papers). Feipu Yang collaborates with scholars based in China and Uzbekistan. Feipu Yang's co-authors include Jingshan Shen, He Yang, Chunhui Wu, Xiangrui Jiang, Fuqiang Zhu, Zhen Wang, Qingjie Zhao, Guanghui Tian, Yuanchao Xie and Hualiang Jiang and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, The Journal of Organic Chemistry and Tetrahedron.

In The Last Decade

Feipu Yang

24 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feipu Yang China 8 79 60 35 35 17 27 156
María Majellaro Spain 10 161 2.0× 65 1.1× 43 1.2× 47 1.3× 12 0.7× 24 264
Ryan C. Schoenfeld United States 10 106 1.3× 93 1.6× 21 0.6× 54 1.5× 9 0.5× 15 224
Arnaud Gohier France 7 101 1.3× 87 1.4× 50 1.4× 19 0.5× 26 1.5× 11 202
Silvia Terreni Italy 11 107 1.4× 170 2.8× 22 0.6× 68 1.9× 9 0.5× 14 275
María Lourdes Linares Belgium 7 123 1.6× 125 2.1× 23 0.7× 96 2.7× 6 0.4× 12 256
Matthew M. Zrada United States 9 94 1.2× 95 1.6× 9 0.3× 32 0.9× 7 0.4× 10 210
Michael F. Parker United States 6 35 0.4× 28 0.5× 17 0.5× 16 0.5× 3 0.2× 12 94
Lorraine F. Lanyon United States 7 109 1.4× 36 0.6× 35 1.0× 31 0.9× 8 0.5× 8 196
Wilson Caulfield United States 7 98 1.2× 52 0.9× 9 0.3× 72 2.1× 5 0.3× 8 158
Laura Zonzini Italy 11 158 2.0× 133 2.2× 12 0.3× 88 2.5× 3 0.2× 19 279

Countries citing papers authored by Feipu Yang

Since Specialization
Citations

This map shows the geographic impact of Feipu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feipu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feipu Yang more than expected).

Fields of papers citing papers by Feipu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feipu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feipu Yang. The network helps show where Feipu Yang may publish in the future.

Co-authorship network of co-authors of Feipu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Feipu Yang. A scholar is included among the top collaborators of Feipu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feipu Yang. Feipu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tian, Yaxin, Jiaxin Cheng, Zhengtao Hu, et al.. (2025). Design, synthesis, and biological profiling of novel aryl-spirocyclic diamine derivatives with potential antidepressant-like properties. European Journal of Medicinal Chemistry. 301. 118198–118198.
3.
Zhu, Fuqiang, et al.. (2025). An Efficient Asymmetric Synthesis of Finerenone via Evans’ Chiral Auxiliary. European Journal of Organic Chemistry. 28(32). 1 indexed citations
4.
Zhou, Liping, Feipu Yang, Jiaxin Cheng, et al.. (2024). Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile. European Journal of Medicinal Chemistry. 275. 116564–116564. 5 indexed citations
5.
Lu, Jie, Cheng Yan, Yumin Zhang, et al.. (2024). Design, synthesis, and evaluation of novel oxyacanthine derivatives for anti-SARS-CoV-2 activity. Bioorganic & Medicinal Chemistry Letters. 113. 129951–129951.
6.
Yang, Feipu, Yan Zhang, Guanghui Tian, et al.. (2024). Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV -2. European Journal of Medicinal Chemistry. 281. 117004–117004. 1 indexed citations
7.
Zhu, Fuqiang, et al.. (2024). An Alternative Approach to Synthesize Sildenafil via Improved Copper-Catalyzed Cyclization. The Journal of Organic Chemistry. 89(10). 7303–7311. 1 indexed citations
8.
9.
Yang, Feipu, et al.. (2024). Impurity study of tecovirimat. Heliyon. 10(9). e29559–e29559. 1 indexed citations
10.
Yang, Feipu, et al.. (2023). Efficient Large-Scale Process for Tecovirimat via Reactive Distillation for the Preparation of Cycloheptatriene. Organic Process Research & Development. 27(11). 1984–1991. 5 indexed citations
11.
Zhao, Chengcheng, Xiangrui Jiang, Liyuan Peng, et al.. (2023). Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids. Journal of Molecular and Cellular Cardiology. 185. 13–25. 2 indexed citations
12.
Liu, Yin, Jinghua Yu, Cheng Huan, et al.. (2022). Pharmacokinetics, mass balance, and metabolism of [14C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertension. Acta Pharmacologica Sinica. 44(1). 221–233. 8 indexed citations
13.
Liu, Yin, et al.. (2021). Facile and Cost-Effective Route for the Synthesis of Simmerafil. Organic Process Research & Development. 25(11). 2432–2437. 1 indexed citations
14.
Wang, Yu, He Yang, Feipu Yang, et al.. (2021). TPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of Schizophrenia. Journal of Pharmacology and Experimental Therapeutics. 378(1). 20–30. 6 indexed citations
15.
Tan, Xiaoqin, Xiangrui Jiang, He Yang, et al.. (2020). Automated design and optimization of multitarget schizophrenia drug candidates by deep learning. European Journal of Medicinal Chemistry. 204. 112572–112572. 31 indexed citations
16.
Yang, Feipu, Yu Wang, Chunhui Wu, et al.. (2019). Continuation of structure–activity relationship study of novel benzamide derivatives as potential antipsychotics. Archiv der Pharmazie. 352(4). e1800306–e1800306. 3 indexed citations
17.
Wu, Chunhui, Yu Wang, Feipu Yang, et al.. (2019). Synthesis and Biological Evaluation of Five‐Atom‐Linker‐Based Arylpiperazine Derivatives with an Atypical Antipsychotic Profile. ChemMedChem. 14(24). 2042–2051. 7 indexed citations
18.
Wang, Yu, Feipu Yang, Chunhui Wu, et al.. (2018). Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect. European Journal of Medicinal Chemistry. 145. 74–85. 15 indexed citations
19.
Wang, Yu, Feipu Yang, Chunhui Wu, et al.. (2018). Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugs. Bioorganic & Medicinal Chemistry Letters. 28(4). 606–611. 7 indexed citations
20.
Yang, Feipu, Xiangrui Jiang, Jianfeng Li, et al.. (2016). Synthesis, structure–activity relationships, and biological evaluation of a series of benzamides as potential multireceptor antipsychotics. Bioorganic & Medicinal Chemistry Letters. 26(13). 3141–3147. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Majellaro Breakdown of academic impact, for papers by Ryan C. Schoenfeld Breakdown of academic impact, for papers by Arnaud Gohier Breakdown of academic impact, for papers by Silvia Terreni Breakdown of academic impact, for papers by María Lourdes Linares Breakdown of academic impact, for papers by Matthew M. Zrada Breakdown of academic impact, for papers by Michael F. Parker Breakdown of academic impact, for papers by Lorraine F. Lanyon Breakdown of academic impact, for papers by Wilson Caulfield Breakdown of academic impact, for papers by Laura Zonzini
Rankless by CCL
2026